Month: February 2010

  Pharmaceutical Counterfeiting in the US: Differentiating Dimensions of the Risk Justin Heinonen and John Spink, 2010 Despite the potentially staggering economic, public safety, and health impact of product counterfeiting generally and pharmaceutical counterfeiting specifically, there are virtually no reliable, systemic data on the problem and no publicly available sources for detailed information on incidents. […]

  The A-CAPPP Product Counterfeiting Incident Database: A Resource for Advancing Research and Policy Justin Heinonen, Jeremy Wilson and A-CAPP Center Staff, 2010 The Need for Data on Product Counterfeiting Despite the staggering economic, health and safety effects of product counterfeiting, there are few evidence‐based lessons on the problem. A major reason there is so […]

  Product Counterfeiting in Australia John Spink, 2010   Product counterfeiting and intellectual property (IP) rights violations have been an ongoing challenge for enforcement and prevention in Australia. The relatively small scale of the Australian economy—with an annual gross domestic product of $800 billion, equivalent to that of Ohio—magnifies the challenge of gathering meaningful data […]

  Combating the Impact of Product Counterfeiting: Defining the Growing Risk to Supply Chain Cost and Service Performance Read the Full Article John Spink, J. Griggs and O.K. Helferich, 2010     This chapter was published in Journal of Distribution Business Management. Subscription may be required to read the full chapter.  2010 Copyright Michigan State […]

  Unveiling the Distinction Between the University and its Academic Researchers: Lessons for Patent Infringement Read the Full Article Jennifer Carter-Johnson, 2010 This Article explores the idea that a faculty member acting in the role of an academic researcher in the scientific disciplines should be viewed in the context of patent law as an autonomous […]